Get notified of page updates

Study: What are the genetics underlying 12 different cancer types?

Printer Friendly Page Read the Original Article

Contents

At a glance In-depth
Findings Limitations                
Questions for your doctor Resources


STUDY AT A GLANCE

This study is about:

Inherited gene mutations found in some patients with one of 12 different cancers.

Why is this study important?

Researchers believe that at least 3% of all cancer cases have a strong hereditary component. One example is mutations, which greatly increase the risk of breast cancer. Other gene mutations also increase cancer risk, but not to the same extent as BRCA. Understanding how often gene mutations that confer moderately higher cancer risk occur in patients is a priority, as these mutations can still be passed to sons and daughters, and may affect patients’ treatment decisions.  According to the study authors, “Such discovery of new cancer susceptibility genes…will be an important step towards generating an actionable catalogue for personalized treatment of cancer.”

Study findings: 

  1. The most commonly mutated genes that increase cancer risk are: , , , , and .
  2. The percentage of patients with gene mutations that increase cancer risk varies among cancers. For example, 19% of ovarian cancer patients in this study had an that increases cancer risk, compared to only 4% of acute myeloid leukemia patients.

What does this mean for me?

This study identifies and catalogues gene mutations that increase a person’s susceptibility to cancer. Ultimately, the goal is to understand which mutations are clinically relevant and how they increase cancer susceptibility, so that health care providers can determine their patients’ cancer risks and treatment plans. However, we have no national guidelines on how to care for patients with some of the newly discovered mutations, or for patients with mutations that have been studied less extensively than BRCA mutations or the mutated genes that cause .  This study is an important step in helping researchers get a complete understanding of the role that inherited mutations play in different cancers. But more work needs to be done to fully assess the clinical relevance of these findings. Patients with mutations in genes that do not have national guidelines outlining risk management options should work with their health care providers to determine appropriate treatments and screenings for themselves and their families.

Posted 3/1/16

Share your thoughts on this XRAYS article by taking our brief survey.

References

Lu C, Xie M, Wendl MC, et al. “Patterns and functional implications of rare variants across 12 cancer types.” Nature Communications. Published online first on December 22, 2015. 

Disclosure

FORCE receives funding from industry sponsors, including companies that manufacture cancer drugs, tests and devices. All XRAYS articles are written independently of any sponsor and are reviewed by members of our Scientific Advisory Board prior to publication to assure scientific integrity.

 

This article is relevant for:

People diagnosed with cancer

This article is also relevant for:

previvors

people with a genetic mutation linked to cancer risk

people with a family history of cancer

people newly diagnosed with cancer

Be part of XRAY:

Expert Guidelines
Expert Guidelines

National Comprehensive Cancer Network guidelines regarding who should undergo genetic counseling and testing recommend speaking with a genetics expert about genetic testing if you have been diagnosed with breast cancer and any of the following apply to you:     

  • You have a blood relative who has tested positive for an inherited mutation 
  • You have any of the following:  
    • Breast cancer at age 50 or younger. 
    • Male breast cancer at any age.
    • Ovarian cancer at any age. 
    • at any age.
    • Two separate breast cancer diagnoses.
    • Eastern European Jewish ancestry and breast cancer at any age.
    • Lobular breast cancer and a family history of diffuse gastric cancer.
    • breast cancer and are at high-risk for recurrence.
    • Tumor testing shows a mutation in a gene that is associated with .

OR 

  • You have one or more close family members who have had:  
    • Young-onset or rare cancers.
    • Breast cancer at age 50 or younger.
    • Triple-negative breast cancer.
    • Male breast cancer, ovarian cancer, pancreatic cancer or  prostate cancer at any age.
    • Two separate cancer diagnoses.
    • Metastatic prostate cancer or prostate cancer that is high-risk or very-high-risk. 

The American Society of Breast Cancer Surgeons (ASBrS) released guidelines in 2019 recommending that all women diagnosed with breast cancer have access to genetic testing for inherited mutations in breast cancer genes. 

If you are uncertain whether you meet the guidelines above and you are interested in or considering genetic testing, you should speak with a cancer genetics expert

Updated: 07/28/2023

Expert Guidelines
Expert Guidelines

National Comprehensive Cancer Network (NCCN) guidelines recommend genetic counseling and testing for anyone diagnosed at any age with epithelial ovarian, or primary peritoneal cancer.

Updated: 11/13/2023

Expert Guidelines
Expert Guidelines

The National Comprehensive Cancer Network guidelines recommend genetic counseling and testing for the following people with prostate cancer who have:

  • a tumor test result that suggests an inherited mutation
    • for example, a tumor with a BRCA1, BRCA2 or ATM mutation may indicate an inherited mutation in one of those genes 
  • a blood relative who tested positive for an inherited mutation in a gene linked to prostate cancer
  • metastatic prostate cancer diagnosed at any age
  • prostate cancer that has spread to the
  • localized prostate cancer (hasn’t spread beyond the prostate) that is considered very high-risk or high-risk
  • intermediate-risk prostate cancer with intraductal or cribriform features listed on the
  • a diagnosis of male breast cancer
  • Eastern European (Ashkenazi) Jewish ancestry
  • one or more relatives with:
    • breast, colorectal or endometrial cancer diagnosed at age 50 or younger
    • male breast cancer, triple negative breast cancer, ovarian cancer or pancreatic cancer at any age
    • metastatic, regional, very-high-risk, or high-risk prostate cancer at any age
  • one or more close relatives with prostate cancer diagnosed at age 60 or younger
  • three or more relatives on the same side of the family with biliary tract, breast, colorectal, endometrial, glioblastoma, prostate or other cancers

Speak with a genetic counselor if you have questions about whether you meet guidelines for genetic testing. 

Updated: 02/01/2024

Expert Guidelines
Expert Guidelines

National Comprehensive Cancer Network (NCCN) guidelines for genetic counseling and testing recommend speaking with a genetics expert about genetic testing for people diagnosed with colorectal or endometrial cancer who have any of the following:

  • A tumor test result that suggests an inherited mutation (for example, an MSI-H or tumor). 
  • A blood relative who tested positive for an inherited mutation linked to cancer.
  • Colorectal or endometrial cancer diagnosed before age 50.
  • Diagnoses of more than one cancer.
  • A family history of one or more first- or second-degree relatives with any of the following types of cancer diagnosed before age 50 or two or more first- or second-degree relatives with any of the following cancers diagnosed at any age:
    • colorectal
    • endometrial
    • ovarian
    • gastric
    • small bowel
    • biliary tract
    • pancreatic
    • urothelial
    • brain (usually glioblastoma)
  • Colorectal cancer and a personal history of polyps:
    • 10 or more adenomatous
    • 2 or more hamartomatous polyps
    • 5 or more serrated polyps close to the rectum

Updated: 11/12/2023

Questions To Ask Your Doctor
Questions To Ask Your Doctor

  • I carry a mutation in (BRIP1, PALB2, ATM, RAD51C, RAD51D, or ) What does this mean for me and my family?
  • I have an extensive family history of breast cancer, but my family does not carry a BRCA mutation. Should I consider genetic testing that looks for mutations in other genes?
  • I had breast cancer before age 50 but tested negative for a mutation in BRCA. Should I consider genetic testing that looks for mutations in other genes?

Open Clinical Trials
Open Clinical Trials

The following clinical trials include genetic counseling and testing. 

Other genetic counseling or testing studies may be found here.

 

Updated: 02/29/2024

Peer Support
Peer Support

FORCE offers many peer support programs for people with inherited mutations. 

Updated: 08/06/2022

Find Experts
Find Experts

The following resources can help you locate a genetics expert near you or via telehealth.

Finding genetics experts

  • The National Society of Genetic Counselors website has a search tool for finding a genetic counselor by specialty and location or via telehealth. 
  • InformedDNA is a network of board-certified genetic counselors providing this service by telephone. They can also help you find a qualified expert in your area for face-to-face genetic counseling if that is your preference. 
  • Gene-Screen is a third-party genetic counseling group that can help educate, support and order testing for patients and their families. 
  • JScreen is a national program from Emory University that provides low-cost at-home genetic counseling and testing with financial assistance available.
  • Grey Genetics provides access to genetic counselors who offer genetic counseling by telephone. 
  • The Genetic Support Foundation offers genetic counseling with board-certified genetic counselors. 

Related experts

Genetics clinics

Other ways to find experts

Updated: 07/21/2023

Who covered this study?

New York Post

Scientists say cancer susceptibility is genetic This article rates 3.5 out of 5 stars

Oncotherapy Network

Investigators identify patterns of rare germline variants in 12 cancer types This article rates 3.5 out of 5 stars

Medical News Today

Study reveals how hereditary gene mutations affect risk of certain cancers This article rates 3.5 out of 5 stars

How we rated the media

Back to XRAY Home